Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides

Am J Physiol. 1999 Dec;277(6):L1158-64. doi: 10.1152/ajplung.1999.277.6.L1158.

Abstract

Earlier work from this laboratory found that fibroblasts isolated from fibrotic human lung [human interstitial pulmonary fibrosis (HIPF)] secrete a soluble inducer(s) of apoptosis in alveolar epithelial cells (AECs) in vitro [B. D. Uhal, I. Joshi, A. True, S. Mundle, A. Raza, A. Pardo, and M. Selman. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L819-L828, 1995]. The cultured human fibroblast strains most active in producing the apoptotic activity contained high numbers of stellate cells expressing alpha-smooth muscle actin, a myofibroblast marker. The apoptotic activity eluted from gel-filtration columns only in fractions corresponding to proteins. Western blotting of the protein fraction identified immunoreactive angiotensinogen (ANGEN), and two-step RT-PCR revealed expression of ANGEN by HIPF fibroblasts but not by normal human lung fibroblasts. Specific ELISA detected angiotensin II (ANG II) at concentrations sixfold higher in HIPF-conditioned medium than in normal fibroblast-conditioned medium. Pretreatment of the concentrated medium with purified renin plus purified angiotensin-converting enzyme (ACE) further increased the ELISA-detectable ANG II eightfold. Apoptosis of AECs in response to HIPF-conditioned medium was completely abrogated by the ANG II receptor antagonist saralasin (50 microg/ml) or anti-ANG II antibodies. These results identify the protein inducers of AEC apoptosis produced by HIPF fibroblasts as ANGEN and its derivative ANG II. They also suggest a mechanism for AEC death adjacent to HIPF myofibroblasts [B. D. Uhal, I. Joshi, C. Ramos, A. Pardo, and M. Selman. Am. J. Physiol. 275 (Lung Cell. Mol. Physiol. 19): L1192-L1199, 1998].

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin II / analysis
  • Angiotensin II / immunology
  • Angiotensin II / metabolism*
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensinogen / genetics
  • Angiotensinogen / metabolism
  • Antibodies
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Blotting, Western
  • Captopril / pharmacology
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay
  • Fibroblasts / cytology
  • Fibroblasts / metabolism
  • Fibrosis
  • Flow Cytometry
  • Gene Expression / physiology
  • Humans
  • Peptidyl-Dipeptidase A / metabolism
  • Pulmonary Alveoli / enzymology
  • Pulmonary Alveoli / pathology*
  • Saralasin / pharmacology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antibodies
  • Angiotensinogen
  • Angiotensin II
  • Captopril
  • Peptidyl-Dipeptidase A
  • Saralasin